Date | Company Name | Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|---|
Oct 11, 2022 | Treeline Biosciences | Series A | — | Biotechnology | — |
Jul 18, 2022 | Immunocore | Post-IPO Equity | — | Biotechnology | — |
Dec 7, 2021 | Freenome | Series D | — | Biotechnology | — |
Jun 25, 2021 | Kindbody | Series C | — | Employee Benefits | — |
May 11, 2021 | Caris Life Sciences | Private Equity(PE) | — | Biotechnology | — |
Mar 22, 2021 | Aura Biosciences | Series Unknown | — | Biotechnology | — |
Jan 19, 2021 | Verve Therapeutics | Series B | — | Biotechnology | — |
Aug 26, 2020 | Freenome | Series C | — | Biotechnology | — |
Jul 8, 2020 | Kindbody | Series B | — | Employee Benefits | — |
Mar 2, 2020 | Immunocore | Series B | — | Biotechnology | — |
May 16, 2017 | Synlogic | Series C | — | Biotechnology | — |
Jul 18, 2016 | Ardelyx | Post-IPO Equity | — | Biotechnology | — |
Jun 22, 2015 | Ardelyx | Post-IPO Equity | — | Biotechnology | — |
May 12, 2015 | BeiGene | Series B | — | Biotechnology | — |
May 7, 2015 | Adaptive Biotechnologies | Series F | — | Biotechnology | — |
Apr 30, 2015 | Mirna Therapeutics | Series D | — | Biotechnology | — |
Oct 13, 2014 | Invitae | Series F | — | Biotechnology | — |